2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- and Nerve Degeneration

2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- has been researched along with Nerve Degeneration in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Moy, LY; Sonsalla, PK; Zeevalk, GD	1
German, DC; Lane, K; Liang, CL; Manaye, KF; Sonsalla, PK	1

Other Studies

2 other study(ies) available for 2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- and Nerve Degeneration

Article	Year
Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures. Journal of neurochemistry, 2000, Volume: 74, Issue:4 Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Biological Transport; Carbon Radioisotopes; Cells, Cultured; Corpus Striatum; Dopamine; Energy Metabolism; Free Radicals; gamma-Aminobutyric Acid; Lactic Acid; Male; Malonates; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Microdialysis; Nerve Degeneration; Neurons; Neuropeptides; Parkinson Disease; Presynaptic Terminals; Synaptic Vesicles; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins	2000
Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons. Neuroscience, 2000, Volume: 101, Issue:4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Cell Count; Drug Synergism; Locus Coeruleus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Mice; Nerve Degeneration; Neurons; Neuropeptides; Norepinephrine; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2000

Article

Year

Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures.

Journal of neurochemistry, 2000, Volume: 74, Issue:4

Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Biological Transport; Carbon Radioisotopes; Cells, Cultured; Corpus Striatum; Dopamine; Energy Metabolism; Free Radicals; gamma-Aminobutyric Acid; Lactic Acid; Male; Malonates; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Microdialysis; Nerve Degeneration; Neurons; Neuropeptides; Parkinson Disease; Presynaptic Terminals; Synaptic Vesicles; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins

2000

Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons.

Neuroscience, 2000, Volume: 101, Issue:4

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Cell Count; Drug Synergism; Locus Coeruleus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Mice; Nerve Degeneration; Neurons; Neuropeptides; Norepinephrine; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins

2000